Search results
There's No Escaping Biocept, Inc.'s (NASDAQ:BIOC) Muted Revenues Despite A 49% Share Price Rise
Simply Wall St. via Yahoo Finance· 1 year agoThose holding Biocept, Inc. (NASDAQ:BIOC) shares would be relieved that the share price has...
Biocept, Inc. (NASDAQ:BIOC) Is Expected To Breakeven In The Near Future
Simply Wall St. via Yahoo Finance· 10 months agoWe feel now is a pretty good time to analyse Biocept, Inc.'s (NASDAQ:BIOC) business as it appears...
6 F-Rated Penny Stocks Not Worth Your Dime
InvestorPlace via Yahoo Finance· 1 year agoAs the adage goes, “where there’s risk, there’s reward.” Unfortunately, this is not universal when it comes to penny stocks. While there are plenty of...
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
InvestorPlace via Yahoo Finance· 9 months agoInvesting in biotech stocks can be challenging. The rewards can be great when your company hits on a...
Why Is Cancer Diagnostic Focused Biocept Stock Trading Higher Today?
Benzinga via Yahoo Finance· 9 months agoBiocept Inc (NASDAQ: BIOC) shares are trading higher after the company signed a non-exclusive...
OncoCyte (OCX) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoOncoCyte (OCX) delivered earnings and revenue surprises of 46.15% and 17.32%, respectively, for the...
EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System...
Benzinga via Yahoo Finance· 9 months agoPlus Therapeutics Inc (NASDAQ: PSTV) has expanded its supply agreement with Biocept Inc (NASDAQ:...
Palo Alto (PANW) & Red Canary Tie Strengthens on Cortex XDR
Zacks via Yahoo Finance· 1 year agoPalo Alto Networks PANW recently expanded partnership with the Colorado-headquartered pioneer of...